NCT00472264View on ClinicalTrials.gov

A Study To Investigate The Ability To Use 18FDG PET Scanning To Monitor The Effectiveness Of New Drugs In COPD Patients

TerminatedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

November 30, 2008

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
PROCEDURE

PET imaging

Medical imaging assessment

Trial Locations (1)

63110

Pfizer Investigational Site, St Louis

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
collaborator

Washington University School of Medicine

OTHER

lead

Pfizer

INDUSTRY